Balyasny Asset Management
GRTS

Balyasny Asset Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Balyasny Asset Management’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,644
Closed -$11.5K – 3262
2024
Q2 		$11.5K Buy
+18,644
New +$15.8K ﹤0.01% 2489
2023
Q4 		– Sell
-2,037,949
Closed -$3.51M – 2995
2023
Q3 		$3.51M Buy
2,037,949
+155,901
+8% +$277K 0.01% 1222
2023
Q2 		$3.67M Sell
1,882,048
-490,982
-21% -$1.15M 0.01% 1167
2023
Q1 		$6.6M Buy
2,373,030
+318,490
+16% +$910K 0.02% 960
2022
Q4 		$7.09M Buy
+2,054,540
New +$5.87M 0.02% 882

Other funds holding GRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Balyasny Asset Management's GRTS Position: Q3 2024 in Review

Balyasny Asset Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 18,644 shares — an estimated $11.5K sold.

Balyasny Asset Management first reported a position in GRTS in Q4 2022 and held it in 5 quarters. The position peaked at $7.09M in Q4 2022. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • Balyasny Asset Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 18,644 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $11.5K.
  • Balyasny Asset Management first reported a position in Gritstone bio, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • Balyasny Asset Management's Gritstone bio, Inc. Common Stock position peaked at $7.09M in Q4 2022.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Balyasny Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.